Free Trial

Marchex (NASDAQ:MCHX) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Marchex logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Marchex missed estimates: Q earnings were $(0.04) EPS versus a $(0.01) consensus (a $0.03 miss) and revenue was $10.85M vs. $10.97M, with negative profitability metrics (ROE -13.57%, net margin -10.38%).
  • Stock and ownership: MCHX traded at $1.49 with a market cap of $65.83M and a one‑year range of $1.26–$2.31, and institutional investors own about 73.46% of the shares (notably Kanen Wealth recently increased its stake).
  • Analyst sentiment is weak: The average rating is "Reduce" (one Hold, one Sell); Zacks upgraded to Hold while Weiss Ratings remains at Sell.
  • Five stocks to consider instead of Marchex.

Marchex (NASDAQ:MCHX - Get Free Report) issued its earnings results on Wednesday. The technology company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.03), FiscalAI reports. The firm had revenue of $10.85 million during the quarter, compared to analysts' expectations of $10.97 million. Marchex had a negative return on equity of 13.57% and a negative net margin of 10.38%.

Marchex Price Performance

MCHX stock traded up $0.06 during trading on Wednesday, hitting $1.49. 6,749 shares of the company traded hands, compared to its average volume of 17,247. Marchex has a 1 year low of $1.26 and a 1 year high of $2.31. The company has a market cap of $65.83 million, a PE ratio of -13.55 and a beta of 2.05. The stock's 50-day simple moving average is $1.56 and its 200 day simple moving average is $1.67.

Institutional Investors Weigh In On Marchex

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd acquired a new position in shares of Marchex in the 4th quarter valued at $26,000. Jane Street Group LLC acquired a new stake in Marchex during the first quarter valued at $30,000. Manatuck Hill Partners LLC purchased a new position in Marchex in the second quarter valued at $88,000. Finally, Kanen Wealth Management LLC increased its holdings in Marchex by 10.9% in the fourth quarter. Kanen Wealth Management LLC now owns 1,249,399 shares of the technology company's stock valued at $2,099,000 after buying an additional 123,011 shares in the last quarter. Institutional investors and hedge funds own 73.46% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Zacks Research upgraded Marchex from a "strong sell" rating to a "hold" rating in a research report on Thursday, February 12th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Marchex in a research note on Thursday, January 22nd. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Marchex has an average rating of "Reduce".

Read Our Latest Research Report on Marchex

About Marchex

(Get Free Report)

Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.

Featured Stories

Earnings History for Marchex (NASDAQ:MCHX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines